Log in to save to my catalogue

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation...

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a60a5d7d3f44e7b9116ea0a57f6e63f

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers

About this item

Full title

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2020-08, Vol.20 (1), p.728-728, Article 728

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Better biomarkers for assessing risk of relapse in stage I testicular germ cell tumor patients are needed, to complement classical histopathological variables. We aimed to assess the prognostic value of previously suggested biomarkers, related to proliferation (MIB-1 and TEX19) and to immune microenvironment (CXCL12, CXCR4, beta-catenin and MECA-79...

Alternative Titles

Full title

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7a60a5d7d3f44e7b9116ea0a57f6e63f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a60a5d7d3f44e7b9116ea0a57f6e63f

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-020-07220-6

How to access this item